Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Cash Flows (unaudited)

v2.4.0.8
Consolidated Statements of Cash Flows (unaudited) (USD $)
In Thousands, unless otherwise specified
 9 Months Ended
Sep. 28, 2013
Sep. 29, 2012
Cash flows from operating activities:    
Net income $ 29,640 $ 30,704
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 5,393 5,353
(Gain)Loss on disposal of assets 324 84
Gain on investment in business (528) 0
Provision for deferred income taxes (23) 4
Allowance for doubtful accounts 8 44
Stock-based compensation expense 2,124 1,639
(Increase) decrease in, net of assets acquired:    
Accounts receivable (4,514) (2,119)
Inventories (151) (147)
Income taxes receivable 728 120
Other current assets (525) (104)
Other assets 284 (92)
Increase (decrease) in, net of liabilities assumed:    
Accounts payable 1,115 65
Accrued expenses and other liabilities 2,206 3,722
Income taxes payable 679 1,047
Other noncurrent liabilities 21 (219)
Net cash provided by operating activities 36,781 40,101
Cash flows from investing activities:    
Investment in business, net of cash acquired (923) 0
Capital expenditures (14,569) (6,703)
Proceeds from dispositions of equipment 70 56
Purchases of short-term investments (22,945) (25,774)
Proceeds from sale of short-term investments 19,327 6,821
Net cash used in investing activities (19,040) (25,600)
Cash flows from financing activities:    
Proceeds from stock issued 651 506
Dividends to shareholders (7,072) (10,107)
Change in restricted cash 1 3
Net cash used in financing activities (6,420) (9,598)
Effect of exchange rate changes on cash and cash equivalents 691 759
Net increase (decrease) in cash and cash equivalents 12,012 5,662
Cash and cash equivalents, beginning of period 34,478 45,080
Cash and cash equivalents, end of period 46,490 50,742
Cash paid:    
Income taxes 13,440 14,323
Supplemental disclosure of noncash transactions:    
Common stock issued for shared distribution through accrued expenses and other liabilities 3,486 4,407
Common stock issued for deferred director’s compensation through other noncurrent liabilities $ 294 $ 930